Teleflex Incorporated (NYSE:TFX) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC lessened its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 1.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,218 shares of the medical technology company’s stock after selling 75 shares during the period. Yousif Capital Management LLC’s holdings in Teleflex were worth $1,285,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in TFX. Janus Henderson Group PLC grew its position in shares of Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after buying an additional 147,147 shares during the last quarter. State Street Corp grew its holdings in shares of Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock valued at $508,757,000 after purchasing an additional 21,291 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after purchasing an additional 5,746 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in shares of Teleflex by 0.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock worth $105,749,000 after purchasing an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its position in Teleflex by 31.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after purchasing an additional 96,958 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Down 0.4 %

Shares of NYSE:TFX opened at $167.60 on Friday. Teleflex Incorporated has a twelve month low of $166.90 and a twelve month high of $256.85. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a market cap of $7.78 billion, a P/E ratio of 33.32, a P/E/G ratio of 1.72 and a beta of 1.16. The company has a 50 day moving average of $178.87 and a 200-day moving average of $210.08.

Analysts Set New Price Targets

Several brokerages have weighed in on TFX. Royal Bank of Canada dropped their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Truist Financial dropped their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Finally, Mizuho reduced their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Teleflex presently has an average rating of “Moderate Buy” and an average target price of $252.50.

Read Our Latest Stock Report on TFX

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.